Work

Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C Study

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-128894

Authors: Julie Kanter, John F. Tisdale, Markus Y. Mapara, Janet L. Kwiatkowski, Lakshmanan Krishnamurti, Manfred Schmidt, Alexandra L. Miller, Francis J. Pierciey, Wenmei Huang, Jean-Antoine Ribeil, Alexis A. Thompson, Mark C. Walters

Institutions: University of Alabama at Birmingham, National Institutes of Health, National Heart, Lung, and Blood Institute, Columbia University Irving Medical Center, Columbia University, Children's Hospital of Philadelphia, University of Pennsylvania, Emory University, Children's Healthcare of Atlanta, Bluebird Bio (United States), Northwestern University, Lurie Children's Hospital, UCSF Benioff Children's Hospital

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2991246547

Cites:

Cited by: 21

Related to: 10